Effect of protein modification by malondialdehyde on the interaction between the oxygen-evolving complex 33 kDa protein and photosystem II core proteins.
Previously we observed that the oxygen-evolving complex 33 kDa protein (OEC33) which stabilizes the Mn cluster in photosystem II (PSII), was modified with malondialdehyde (MDA), an end-product of peroxidized polyunsaturated fatty acids, and the modification increased in heat-stressed plants (Yamauchi et al. 2008). In this study, we examined whether the modification of OEC33 with MDA affects its binding to the PSII complex and causes inactivation of the oxygen-evolving complex. Purified OEC33 and PSII membranes that had been removed of extrinsic proteins of the oxygen-evolving complex (PSIIOEE) of spinach (Spinacia oleracea) were separately treated with MDA. The binding was diminished when both OEC33 and PSIIOEE were modified, but when only OEC33 or PSIIOEE was treated, the binding was not impaired. In the experiment using thylakoid membranes, release of OEC33 from PSII and corresponding loss of oxygen-evolving activity were observed when thylakoid membranes were treated with MDA at 40 degrees C but not at 25 degrees C. In spinach leaves treated at 40 degrees C under light, maximal efficiency of PSII photochemistry (F(v)/F(m) ratio of chlorophyll fluorescence) and oxygen-evolving activity decreased. Simultaneously, MDA contents in heat-stressed leaves increased, and OEC33 and PSII core proteins including 47 and 43 kDa chlorophyll-binding proteins were modified with MDA. In contrast, these changes were to a lesser extent at 40 degrees C in the dark. These results suggest that MDA modification of PSII proteins causes release of OEC33 from PSII and it is promoted in heat and oxidative conditions.
Graduate School of Agricultural Science, Kobe University, Nada-ku, Kobe, Japan. yamauchi@kobe-u.ac.jp
Yasuo
Y
Yamauchi
Yukihiro
Y
Sugimoto
D000171:Acrolein / Q000494:pharmacology; D000447:Aldehydes / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D056148:Chromatography, Reverse-Phase; D006358:Hot Temperature; D007425:Intracellular Membranes / Q000187:drug effects / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D008315:Malondialdehyde / Q000378:metabolism / Q000494:pharmacology*; D045332:Photosystem II Protein Complex / Q000378:metabolism*; D018515:Plant Leaves / Q000187:drug effects / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D011499:Protein Processing, Post-Translational / Q000187:drug effects*; D018724:Spinacia oleracea / Q000187:drug effects* / Q000378:metabolism*; D013312:Stress, Physiological / Q000187:drug effects; D020524:Thylakoids / Q000187:drug effects / Q000378:metabolism
D000447:Aldehydes; D045332:Photosystem II Protein Complex; C064388:oxygen-evolving complex, 33 kDa protein; D008315:Malondialdehyde; D000171:Acrolein; C012796:2-butenal